drugset / Trial / NCT03889470
Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center
RandomizedParallel-groupSingle-blindPrevention
Summary
The investigators will investigate whether administration of Nitroglycerin (NTG) as spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in patients undergoing transradial catheterization in radial center.
Timeline
- Start
- 2018-03-31
- Primary completion
- 2019-09-30
- Completion
- 2019-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NTG | Unknown | 200 ug | Other |
Indications
No indication recorded.